Lifecore Biomedical, Inc.
LFCR Healthcare Drug Manufacturers Specialty & Generic
In the quarter to June 2026, revenue fell 6.25%, EPS fell 216.7%, free cash flow fell 117.0% and total debt rose 15.3%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
Follow LFCR
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
17.24 | 20.80 | 17.47 | 18.86 |
+8 more quarters Free account |
Receivables |
30.46 | 19.44 | 26.16 | 24.75 | |
Inventory |
25.48 | 28.16 | 29.09 | 33.80 | |
Other current assets |
7.57 | 7.45 | 7.66 | 4.39 | |
Total current assets |
83.69 | 77.64 | 82.29 | 83.93 | |
Property, Plant, Equpment (Net) |
123.71 | 125.51 | 127.30 | 128.58 | |
Goodwill and Intangible Assets (Total) |
13.88 | 13.88 | 13.88 | 18.08 | |
Long-term assets (Other) |
8.21 | 8.47 | 8.70 | 4.62 | |
Total non-current assets |
145.81 | 147.86 | 149.89 | 151.28 | |
Total Assets |
229.50 | 225.50 | 232.18 | 235.20 | |
Accounts Payable |
7.53 | 7.01 | 6.21 | 10.12 | |
Accrued Expenses |
14.11 | 13.48 | 17.36 | 19.84 | |
Total current liabilities |
21.64 | 20.50 | 23.57 | 29.96 | |
Long Term Debt (Total) |
185.02 | 147.78 | 167.85 | 160.50 | |
Non-current Revenue (Deferred) |
— | 29.72 | 26.56 | — | |
Non-current Liabilities (Other) |
6.75 | 6.73 | 6.70 | 7.97 | |
Total non-current liabilities |
191.77 | 184.22 | 174.54 | 168.46 | |
Total liabilities |
213.41 | 204.72 | 198.12 | 198.42 | |
Additional Paid In Capital |
210.21 | 209.71 | 208.96 | 207.52 | |
Preferred Stock (Total) |
50.19 | 49.22 | 48.26 | 47.32 | |
Common Stock (Net) |
0.04 | 0.04 | 0.04 | 0.04 | |
Retained Earnings |
(244.34) | (238.18) | (223.20) | (218.09) | |
Common Equity (Total) |
(34.09) | (28.44) | (14.20) | (10.54) | |
Shareholders Equity (Total) |
16.09 | 20.78 | 34.06 | 36.79 | |
Shareholders Equity and Liabilities (Total) |
229.50 | 225.50 | 232.18 | 235.20 | |
Shares (Common) |
37.70 | 37.48 | 37.48 | 37.47 | |
Shares (Preferred) |
0.05 | 0.05 | 0.05 | 0.05 | |
Shareholders Equity (Tangible) |
2.21 | 6.90 | 20.18 | 18.71 | |
Net Debt |
167.78 | 126.98 | 150.38 | 141.64 | |
Total Debt |
185.02 | 147.78 | 167.85 | 160.50 |